BSX holders · CITADEL ADVISORS LLC 13F · BSX stock

CITADEL ADVISORS LLC Boston Scientific Corp (BSX) 13F holding

CITADEL ADVISORS LLC reported 2,806,924 BSX shares valued at $176.13B as of 2026-03-31 (COM). Cached 13F row, not a live tape.

Cached BSX reports from CITADEL ADVISORS LLC
ReportSharesValueClass
2026-03-312,806,924$176.13BCOM
2026-03-311,611,900$101.15BCall
2026-03-311,410,390$88.50BCOM
2026-03-31910,400$57.13BPut
2025-12-313,704,886$353.26BCOM
2025-12-311,070,732$102.09BCOM
2025-12-31606,800$57.86BCall
2025-12-31555,500$52.97BPut
2025-12-3153,800$5.13BCall
2025-12-3144,500$4.24BPut
2025-09-307,087,099$691.91BCOM
2025-09-301,819,146$177.60BCOM
2025-09-30601,400$58.71BCall
2025-09-30503,300$49.14BPut
2025-06-305,230,575$561.82BCOM
2025-06-30782,400$84.04BCall
2025-06-30470,000$50.48BPut
2025-06-30173,730$18.66BCOM

Not investment advice. Cached 13F row, not EDGAR XML.

CITADEL ADVISORS LLC BSX 13F P/E 20, rev $20.07B | Lician